News
Click here for news in Danish.
December 16, 2008 | Company Announcements
Bavarian Nordic upgrades the financial guidance for 2008December 10, 2008 | Company Announcements
Bavarian Nordic A/S issues Financial Calendar for 2009December 01, 2008 | Company Announcements
The Government of Canada procures IMVAMUNE® smallpox vaccine for the country’s biological preparednessNovember 19, 2008 | Company Announcements
Bavarian Nordic A/S – Major Shareholder AnnouncementNovember 19, 2008 | Company Announcements
Bavarian Nordic receives USD 25 million milestone payment after submission of important IMVAMUNE® data to the U.S. Health AuthoritiesNovember 05, 2008 | Company Announcements
Bavarian Nordic reports successful safety data from Phase II study with IMVAMUNE®November 04, 2008 | Company Announcements
Bavarian Nordic A/S – Interim Report for the period 1 January to 30 September 2008October 17, 2008 | Company Announcements
Bavarian Nordic awards warrants to management and certain employees and introduces incentive programme for all employeesOctober 07, 2008 | Company Announcements
Bavarian Nordic announces positive mature Phase II results from newly acquired prostate cancer vaccineAugust 19, 2008 | Company Announcements
Bavarian Nordic A/S – Interim Report for the period 1 January to 30 June 2008August 13, 2008 | Company Announcements
Bavarian Nordic announces partnership with National Cancer Institute in the US and obtains rights to a new vaccine candidateJune 30, 2008 | Company Announcements
Bavarian Nordic files patent infringement suit against Oxford BioMedicaJune 19, 2008 | Company Announcements
Bavarian Nordic reports interim data from Phase I/II studies with breast cancer vaccineJune 03, 2008 | Company Announcements
Bavarian Nordic enters clinical trials with prostate cancer vaccineMay 27, 2008 | Company Announcements
Bavarian Nordic enters clinical trials with HIV multiantigen vaccineMay 26, 2008 | Company Announcements
Bavarian Nordic A/S – Report on the Results of the Extraordinary General Meeting, held 26 May 2008May 21, 2008 | Company Announcements
Bavarian Nordic A/S – Extraordinary General Meeting, proxiesMay 08, 2008 | Company Announcements
Bavarian Nordic A/S – Notice convening extraordinary general meetingApril 30, 2008 | Company Announcements
Bavarian Nordic A/S – Major Shareholder AnnouncementApril 29, 2008 | Company Announcements
Bavarian Nordic A/S – Report on the Results of the Annual General Meeting, held 29 April 2008April 29, 2008 | Company Announcements
Bavarian Nordic A/S – Interim Report for the period 1 January to 31 March 2008April 24, 2008 | Company Announcements
Bavarian Nordic A/S – Annual General Meeting, proxiesApril 14, 2008 | Company Announcements
Bavarian Nordic A/S propose changes in Board of DirectorsApril 10, 2008 | Press Releases
Post-exposure vaccination with IMVAMUNE® protects against lethal poxvirus infectionApril 08, 2008 | Company Announcements
Bavarian Nordic A/S – Board of Directors’ comments to proposed resolutions from shareholder to be considered at the Annual General Meeting